Kilitch Drugs (India) Limited (BOM:524500)

Kilitch Drugs (India) Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	157.74	98.01	189.62	198.46	100.62
Short-Term Investments	-	529.65	495.65	501.09	393.31	472.34
Cash & Short-Term Investments	687.39	687.39	593.66	690.71	591.77	572.96
Cash Growth	15.79%	15.79%	-14.05%	16.72%	3.28%	17.17%
Accounts Receivable	-	1,202	847.39	632.24	542.87	414.12
Other Receivables	-	0.33	0.32	0.34	0.22	0.2
Receivables	-	1,202	847.71	632.58	543.09	414.32
Inventory	-	119.88	215.78	55.82	24.07	52.88
Prepaid Expenses	-	2.65	1.98	0.86	1.58	0.5
Other Current Assets	-	209.93	80.04	79.97	103.53	100.39
Total Current Assets	-	2,222	1,739	1,460	1,264	1,141
Property, Plant & Equipment	-	1,887	928.19	481.2	473.58	464.03
Long-Term Investments	-	228.87	228.6	228.47	226.78	260.68
Goodwill	-	176.93	185.36	193.79	202.21	210.64
Other Intangible Assets	-	2.64	3.51	4.44	2.63	2.34
Long-Term Deferred Tax Assets	-	45.82	28.79	25.63	19.78	15.12
Other Long-Term Assets	-	14.13	14.22	7.15	6.21	4.63
Total Assets	-	4,577	3,128	2,401	2,195	2,098

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	796.47	541.57	255.89	408.75	428.69
Accrued Expenses	-	26.83	17.43	15.97	16.44	14.48
Short-Term Debt	-	301.06	216.54	316.47	221.94	204.32
Current Income Taxes Payable	-	65.66	66.86	53.05	40.39	43.96
Other Current Liabilities	-	25.99	0.7	0.78	1.22	1.34
Total Current Liabilities	-	1,216	843.1	642.16	688.73	692.79
Long-Term Debt	-	586.04	277.7	-	-	-
Pension & Post-Retirement Benefits	-	6.79	2.45	1.72	0.68	2.75
Total Liabilities	-	1,809	1,123	643.88	689.41	695.55

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	349.62	160.82	160.82	155.82	155.82
Additional Paid-In Capital	-	765.33	466.84	466.84	383.26	383.26
Retained Earnings	-	1,569	1,267	1,000	854.29	749.81
Comprehensive Income & Other	-	112.62	128.32	134.95	122.6	101.97
Total Common Equity	2,797	2,797	2,023	1,763	1,516	1,391
Minority Interest	-	-27.86	-18.71	-6.18	-10.17	12.07
Shareholders' Equity	2,769	2,769	2,005	1,757	1,506	1,403
Total Liabilities & Equity	-	4,577	3,128	2,401	2,195	2,098

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	887.09	887.09	494.24	316.47	221.94	204.32
Net Cash (Debt)	-199.7	-199.7	99.42	374.25	369.83	368.64
Net Cash Growth	-	-	-73.44%	1.19%	0.32%	8.11%
Net Cash Per Share	-5.78	-5.90	6.18	11.75	11.87	11.84
Filing Date Shares Outstanding	35.1	34.96	32.16	32.16	31.16	31.16
Total Common Shares Outstanding	35.1	34.96	32.16	32.16	31.16	31.16
Working Capital	-	1,006	896.06	817.77	575.3	448.25
Book Value Per Share	79.99	79.99	62.90	54.81	48.64	44.63
Tangible Book Value	2,617	2,617	1,834	1,565	1,311	1,178
Tangible Book Value Per Share	74.85	74.85	57.03	48.65	42.07	37.80
Land	-	116.92	86.78	86.78	86.13	86.13
Buildings	-	45.19	41.72	40.02	40.02	39.43
Machinery	-	645.82	621.67	568.69	561.19	529.87
Construction In Progress	-	1,400	472.95	59.65	36.19	31.61

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error